Use of Nutritional Supplements and CAM (Complementary and Alternative Medicine) by Prostate and Breast Cancer Patients Undergoing Radiotherapy
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Prostate Cancer
- Sponsor
- Ohio State University Comprehensive Cancer Center
- Enrollment
- 109
- Locations
- 1
- Primary Endpoint
- Assess quality of life using validated instruments during radiation therapy and determine if there is a correlation between CAM use and quality of life.
- Status
- Completed
- Last Updated
- 4 months ago
Overview
Brief Summary
This study was a survey to determine the frequency of Complementary and Alternative Medicine (CAM) use in patients recently diagnosed with breast or prostate cancer who were starting radiation therapy. The survey was repeated at three time points to assess changes in CAM use over time.
Investigators
Steven Clinton
Principal Investigator
Ohio State University Comprehensive Cancer Center
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Assess quality of life using validated instruments during radiation therapy and determine if there is a correlation between CAM use and quality of life.
Time Frame: Up to 1 year
Assess radiation therapy toxicity using standardized criteria from the Oncology Nursing Society and determine if there is a correlation between CAM use and measures of toxicity.
Time Frame: Up to 1 year
To determine predictive factors for CAM and nutritional supplement use, such as age, race, income, education, marital status, or tobacco/alcohol use.
Time Frame: Up to 1 year
Quantitate the various types of CAM therapy utilized by men with prostate cancer and women with breast cancer who are currently undergoing radiation.
Time Frame: Up to 1 year
Quantitate the various types of CAM therapy utilized by men with prostate cancer and women with breast cancer who are currently undergoing radiation therapy at The James Cancer Hospital and Solove Research Institute. Nutrient supplements and alternative medication use is the primary focus of the assessment.
Determine if patients change their patterns of CAM use prior to, during, or after radiation treatment.
Time Frame: Up to 1 year